Delta 9 Cannabis (TSX:DN) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

DN Panoramica delle azioni

Delta 9 Cannabis Inc. opera, insieme alle sue controllate, come un'azienda di cannabis integrata.

DN analisi fondamentale
Punteggio fiocco di neve
Valutazione	4/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	2/6
Dividendi	0/6

Premi

Negoziato a 97.9% al di sotto della nostra stima del suo valore equo

Analisi del rischio

Patrimonio netto negativo

Non ha una capitalizzazione di mercato significativa ( CA$4M )

Gli utili sono diminuiti del 51.6% all'anno negli ultimi 5 anni

Prezzo delle azioni altamente volatile negli ultimi 3 mesi

+ 1 più rischio

Delta 9 Cannabis Inc. Concorrenti

Entourage Health

TSXV:ENTG

CA$4.6m

Appili Therapeutics

TSX:APLI

CA$4.9m

MindBio Therapeutics

CNSX:MBIO

CA$4.0m

THC Biomed Intl

CNSX:THC

CA$3.3m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Delta 9 Cannabis
Prezzi storici delle azioni
Prezzo attuale dell'azione	CA$0.01
Massimo di 52 settimane	CA$0.07
Minimo di 52 settimane	CA$0.005
Beta	1.21
1Variazione di 1 mese	0%
Variazione a 3 mesi	-50.00%
Variazione di 1 anno	-77.78%
3Variazione a 3 anni	-97.62%
Variazione a 5 anni	-98.90%
Variazione dall'IPO	-99.65%

Notizie e aggiornamenti recenti

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

Jun 21

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

May 10

Recent updates

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

Jun 21

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

May 10

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Mar 26

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

Mar 26

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

Sep 09

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Jul 28

John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares

Dec 24

Rendimenti per gli azionisti

	DN	CA Pharmaceuticals	CA Mercato
7D	0%	-6.0%	0.9%
1Y	-77.8%	37.6%	15.8%

Ritorno vs Industria: DN ha avuto una performance inferiore rispetto al Canadian Pharmaceuticals che ha registrato un rendimento 43.5 % nell'ultimo anno.

Rendimento vs Mercato: DN ha avuto una performance inferiore al mercato Canadian che ha registrato un rendimento 15.1 % nell'ultimo anno.

Volatilità dei prezzi

Is DN's price volatile compared to industry and market?
DN volatility
DN Average Weekly Movement	54.2%
Pharmaceuticals Industry Average Movement	10.3%
Market Average Movement	8.0%
10% most volatile stocks in CA Market	16.6%
10% least volatile stocks in CA Market	3.1%

Prezzo delle azioni stabile: Il prezzo delle azioni di DN è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale di DN è aumentata da 36% a 51% nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2001	320	John Arbuthnot	www.delta9.ca

Delta 9 Cannabis Inc. opera, insieme alle sue consociate, come un'azienda integrata di cannabis. L'azienda si occupa di coltivazione, lavorazione, estrazione, distribuzione all'ingrosso, vendita al dettaglio e vendita di prodotti a base di cannabis per uso medico e ricreativo. I suoi prodotti includono fiori di cannabis essiccati, pre-roll e cannabis essiccata setacciata, oltre a oli e prodotti estratti e derivati.

Delta 9 Cannabis Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Delta 9 Cannabis con la sua capitalizzazione di mercato?
DN statistiche fondamentali
Capitalizzazione di mercato	CA$3.65m
Guadagni(TTM)	-CA$19.60m
Ricavi(TTM)	CA$70.65m

0.1x

Rapporto P/S

-0.2x

Rapporto P/E

DN è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
DN Conto economico (TTM)
Ricavi	CA$70.65m
Costo del fatturato	CA$58.10m
Profitto lordo	CA$12.55m
Altre spese	CA$32.15m
Guadagni	-CA$19.60m

Ultimi guadagni dichiarati

Mar 31, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.054
Margine lordo	17.77%
Margine di profitto netto	-27.74%
Rapporto debito/patrimonio netto	-447.3%

Come si è comportato DN nel lungo periodo?

Vedi performance storica e confronto

DN Panoramica delle azioni

Premi

Analisi del rischio

Delta 9 Cannabis Inc. Concorrenti

TSXV:ENTG

CA$4.6m

TSX:APLI

CA$4.9m

CNSX:MBIO

CA$4.0m

CNSX:THC

CA$3.3m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024

Co-Founder exercised options to buy CA$31k worth of stock.

Recent updates

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024

Co-Founder exercised options to buy CA$31k worth of stock.

Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022)

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

New major risk - Shareholder dilution

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)

Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

New major risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022)

New major risk - Share price stability

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023

Co-Founder recently sold CA$99k worth of stock

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.037 loss in 1Q 2022)

Delta 9 Cannabis Inc. to Report Q1, 2023 Results on May 15, 2023

Delta 9 Cannabis Inc. to Report Q4, 2022 Results on Mar 31, 2023

Co-Founder recently sold CA$52k worth of stock

Delta 9 Cannabis Inc. Announces Changes to Board of Directors

Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.011 loss in 3Q 2021)

Price target decreased to CA$0.80

Insufficient new directors

Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022

Delta 9 Cannabis Inc. to Report Q3, 2022 Results on Nov 14, 2022

Delta 9 Cannabis Inc. (TSX:DN) acquired All or Substantially All Assets from 10552763 Canada Corp.

Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?

Price target decreased to CA$0.80

Second quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.014 loss in 2Q 2021)

Delta 9 Cannabis Inc. (TSX:DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million.

Joanne Duhoux-Defehr Resigns from Board of Directors of Delta 9 Cannabis Inc

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Price target decreased to CA$0.95

First quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.042 loss in 1Q 2021)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022

Delta 9 Cannabis Inc., Annual General Meeting, Jun 29, 2022

Insufficient new directors

Full year 2021 earnings released: CA$0.11 loss per share (vs CA$0.072 loss in FY 2020)

Delta 9 Cannabis Inc. announced that it has received CAD 9.6 million in funding from Sundial Growers Inc.

Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021

Is Delta 9 Cannabis (TSE:DN) A Risky Investment?

Insufficient new directors

Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.07 loss in 3Q 2020)

Independent Director recently sold CA$126k worth of stock

Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt

Price target increased to CA$1.13

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 2Q 2020)

Delta 9 Cannabis Inc. Announces Health Canada Approval for Perimeter Expansion and Vault Area

Price target decreased to CA$1.04

Co-Founder exercised options to buy CA$63k worth of stock.

Co-Founder recently bought CA$53k worth of stock

Co-Founder recently bought CA$53k worth of stock

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three-Month and Six-Month Period Ending June 30, 2021

Co-Founder recently sold CA$138k worth of stock